PMID: 9167521Jun 1, 1997Paper

Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients

The American Journal of Psychiatry
M BergerD Riemann

Abstract

The authors' goal was to test the hypothesis that the antidepressant effect of total sleep deprivation can be maintained by initially avoiding sleep during a supposedly "critical" time period in the early morning. They studied 33 inpatients with major depression, melancholic type, all of whom responded positively to total sleep deprivation. Twelve of the patients were men and 21 were women; their mean age was 46.7 years (SD = 13.7). After total sleep deprivation, the patients started a sleep schedule from 5:00 p.m. to 12:00 midnight, which then was shifted back by 1 hour each day until a sleep time of 11:00 p.m. to 6:00 a.m. was reached. Twenty (61%) of the 33 patients who responded to total sleep deprivation with an improved state of mood maintained this improvement during sleep phase advance therapy. Drug-free and medicated patients did not differ from each other. The rapid amelioration of mood observed with total sleep deprivation can be preserved with a succeeding phase shift of the sleep period.

Citations

Nov 6, 2013·Pharmacology & Therapeutics·M DreslerF Holsboer
Aug 25, 1999·Biological Psychiatry·A Wirz-Justice, R H Van den Hoofdakker
Nov 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Francesco BenedettiEnrico Smeraldi
Nov 12, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·José R Maldonado
Oct 27, 2012·Neurologic Clinics·Andrew D Krystal
Jun 2, 2012·Experimental Cell Research·Yang Guo, Pingfu Feng
Feb 24, 2009·Journal of Affective Disorders·Lucian Moscovici, Moshe Kotler
Oct 22, 2008·Critical Care Clinics·José R Maldonado
Oct 1, 2008·Sleep Medicine·Sarah Laxhmi ChellappaChristian Cajochen
Aug 11, 2007·Sleep Medicine Reviews·Francesco BenedettiEnrico Smeraldi
Mar 31, 2007·Pharmacology & Therapeutics·Colleen A McClung
Dec 11, 2008·Psychiatry and Clinical Neurosciences·Raffaella ZanardiCristina Colombo
Nov 17, 2015·Sleep Medicine Clinics·Stephanie G Jones, Ruth M Benca
Jul 28, 2012·Journal of Affective Disorders·Masaru EchizenyaTetsuo Shimizu
Jun 19, 2013·Journal of Affective Disorders·Arun V Ravindran, Tricia L da Silva
Sep 25, 2001·Depression and Anxiety·Martin P. Szuba
Sep 25, 2001·Depression and Anxiety·B L Ringel, M P Szuba
Jan 6, 2010·Pharmaceuticals·Rodrigo Machado-VieiraCarlos A Zarate
Jan 25, 2017·Molecular Psychiatry·T A Wehr
Aug 4, 2004·International Clinical Psychopharmacology·Francesco BenedettiEnrico Smeraldi
Sep 22, 2012·Journal of Psychiatric Practice·John F Gottlieb, Michael Terman
Feb 1, 2019·The European Journal of Neuroscience·Anna Wirz-Justice, Francesco Benedetti
Jul 25, 2006·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Venkataramanujan SrinivasanDaniel P Cardinali
Feb 28, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·E Holsboer-Trachsler, E Seifritz
Jan 29, 2002·Anesthesia and Analgesia·Michael Hanania, Eric Kitain
Jul 5, 2011·Expert Review of Neurotherapeutics·Sara Dallaspezia, Francesco Benedetti
Aug 4, 2011·Neuropsychobiology·Francesco Benedetti, Cristina Colombo
Jun 1, 1999·Journal of Clinical Psychopharmacology·F BenedettiE Smeraldi
Oct 20, 2015·Current Psychiatry Reports·Sara DallaspeziaFrancesco Benedetti
Jul 29, 2003·Genes, Brain, and Behavior·A EastonF W Turek
Sep 6, 2003·Acta Psychiatrica Scandinavica. Supplementum·M BergerD Riemann
May 7, 2002·American Journal of Medical Genetics·Robert H LenoxHusseini K Manji
Jul 1, 2010·Expert Review of Neurotherapeutics·Ulrich-Michael HemmeterJürgen-Christian Krieg
Oct 14, 2019·Journal of Affective Disorders·Clara HumpstonDavid Veale

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.